In vivo effects, underlying signaling pathways and mechanism of action of ghrelin receptor agonist against pathological alpha-synuclein accumulation

2019/35/D/NZ7/03200

Keywords

Descriptors

  • NZ7_014: Farmacja, farmakoterapia, farmakologia
  • NZ4_004: Patofizjologia ogólna
  • NZ4_009: Neurobiologia systemowa

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

dr Piotr Chmielarz

Number of co-investigators in the project: 5

Call

SONATA 15 – announced on 2019-09-16

Amount awarded
1 055 333 PLN
Project start date
2020-07-20
Project end date
2026-07-19
Project duration
72 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

Publication in academic press/journals (2)

  1. Alpha-synuclein preformed fibrils: a tool to understand Parkinson's disease and develop disease modifying therapy

    Authors:
    Piotr Chmielarz, Andrii Domanskyi
    Academic press:
    Neural Regeneration Research (year: 2021, volume: 16(11), pages: 2219-2221), Publisher: Wolters Kluwer Medknow Publications, India
    Status:
    Published
    DOI:
    10.4103/1673-5374.310686 – link to the publication
  2. Cell Culture Media, Unlike the Presence of Insulin, Affect α-Synuclein Aggregation in Dopaminergic Neurons

    Authors:
    Irena Hlushchuk, Justyna Barut, Mikko Airavaara, Kelvin Luk, Andrii Domanskyi, Piotr Chmielarz
    Academic press:
    Biomolecules (year: 2022, volume: 12, pages: 563), Publisher: MDPI AG, Switzerland
    Status:
    Published
    DOI:
    10.3390/biom12040563 – link to the publication

Articles in post-conference publications (2)

  1. Ghrelin receptor agonist MK-0677 alleviates motor impairments caused by spreading alpha-synuclein aggregation in bilaterally alpha-synuclein fibrils injected mice

    Authors:
    Maziarz K., Jankowska-Kieltyka M., Barut J., Chmielarz P.
    Conference:
    Neuroscience Applied tom 1 Abstracts of the 35th ECNP Congress 2022 (year: 2022, volume: 35th ECNP Congress 2022, pages: 100246), Publisher: Elsevier B.V.
    Date:
    conference 15-18.10.2022
    Status:
    Published
    DOI:
    10.1016/j.nsa.2022.100246 – link to the publication
  2. Ghrelin receptor agonist rescues motor impairments and protects dopamine neurons in alpha-synuclein aggregation model

    Authors:
    Katarzyna Maziarz, Monika Jankowska-Kiełtyka, Justyna Barut, Piotr Chmielarz
    Conference:
    Neuroscience Applied (year: 2023, volume: ECNP Workshop for Early Career Scientists in Europe, pages: 101030), Publisher: Elsevier B.V.
    Date:
    conference 16-19 March 2023
    Status:
    Published
    DOI:
    10.1016/j.nsa.2023.101030. – link to the publication

« New search

Graphic design and implementation: Jakub Piotrowski